Leucine, a dietary amino acid, binds to a specific site on the Cav3.1 ion channel and reduces the voltage needed for the channel to open, which leads to activation of neurons.
See the scientific wording
Leucine binds to a hydrophobic pocket in the Cav3.1 channel and lowers its voltage activation threshold, enabling neuronal activation in response to dietary leucine.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Case-Control StudyAnimal2026
Leucine, an amino acid in protein, sticks to a specific spot on a brain channel called Cav3.1, making it easier for brain cells to turn on when leucine is present. This helps signal fullness and reduce appetite.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When leucine from food enters the brain, it attaches to a specific spot on a calcium channel called Cav3.1 in certain nerve cells. This makes the channel open more easily when the cell is slightly electrically stimulated. Once open, calcium flows into the cell, turning it on. These activated nerve cells send signals that stop hunger and reduce food intake.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Leucine, a dietary amino acid, binds to a specific site on the Cav3.1 ion channel and reduces the voltage needed for the channel to open, which leads to activation of neurons.
Mechanism
1 studyLeucine from food binds to a specific channel in brain cells that control hunger, making it easier for the channel to open. When it opens, calcium flows in and turns the cell on. These activated cells send signals that stop you from feeling hungry.
When leucine from food enters the brain, it attaches to a specific spot on a calcium channel called Cav3.1 in certain nerve cells. This makes the channel open more easily when the cell is slightly electrically stimulated. Once open, calcium flows into the cell, turning it on. These activated nerve cells send signals that stop hunger and reduce food intake.
Leucine binds to a hydrophobic pocket in the Cav3.1 voltage-gated calcium channel
Binding of leucine reduces the voltage threshold required for Cav3.1 channel opening
Cav3.1 channel opening allows calcium influx into hypothalamic POMC neurons
Calcium influx activates POMC neurons, triggering downstream anorectic signaling
Activated POMC neurons suppress appetite and promote weight loss via central satiety pathways
Evidence from Studies
Supporting (1)
Community contributions welcome
Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein
Leucine, an amino acid in protein, sticks to a specific spot on a brain channel called Cav3.1, making it easier for brain cells to turn on when leucine is present. This helps signal fullness and reduce appetite.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Leucine-Induced Cav3.1 Channel Modulation and Neuronal Excitability Across In Vitro and In Vivo Models
Systematic review and meta-analysis of all peer-reviewed in vitro, animal, and human studies measuring leucine binding to Cav3.1, changes in voltage activation threshold, and downstream neuronal firing rates.
Double-Blind Placebo-Controlled Trial of Oral Leucine Supplementation on Cav3.1-Dependent Neuronal Activity in Healthy Adults
Randomized, double-blind, placebo-controlled trial in healthy adult humans comparing high-dose leucine supplementation versus placebo, measuring Cav3.1 channel activity via electrophysiology and neuronal activation via fMRI or EEG over 4 weeks.
Prospective Cohort Study of Dietary Leucine Intake and Cav3.1-Related Neurophysiological Markers in a General Population
Prospective cohort study following 10,000 adults over 5 years, measuring dietary leucine intake via food diaries and assessing Cav3.1-related neuronal activity via repeated neurophysiological testing.
Patch-Clamp Electrophysiology of Cav3.1 Channels Expressed in HEK293 Cells Exposed to Physiological Concentrations of Leucine
In vitro patch-clamp experiments on HEK293 cells transfected with human Cav3.1 channels, exposing them to graded concentrations of leucine (0–10 mM) and measuring changes in voltage-dependent activation kinetics.
Electrophysiological and Behavioral Assessment of Cav3.1 Knockout Mice Fed High-Leucine Diets
Comparison of neuronal firing patterns and behavioral responses to leucine administration in wild-type mice versus Cav3.1 knockout mice, with dietary leucine controlled over 8 weeks.